At CPHI Frankfurt (28 to 30 October), innovative excipients by Lubrizol will be exhibited, pushing the boundaries of pharmaceutical advancements. These next-generation excipients are designed to improve the solubility, bioavailability and palatability of APIs and nutraceuticals, ensuring better patient outcomes.
Cutting-edge products to watch
- Apisolex™ Polymer Excipient: Offering up to a 50 000-fold improvement in the solubility of injectable and parenteral drug formulations, Apisolex™ polymer tackles the challenges of poorly soluble APIs. It delivers high drug-loading capacity and enables life-saving therapeutic advancements.
- Apinovex™ Polymer Excipient: Boost oral API solubility and dissolution with Apinovex™, which simplifies the creation of stable, compact dosage forms. In addition, it supports formats such as amorphous solid dispersions and custom tablets with multiple APIs.
- Carbopol® Polymer Excipient: A versatile excipient across oral, topical and supplement platforms. Its benefits include taste masking, texture enhancement and ingredient stability. Furthermore, it adapts seamlessly to diverse formats, including gummies, tablets, capsules and creams.
Meet Lubrizol’s experts
Visit Stand 8.0M71 at CPHI Frankfurt to get insights into Lubrizol‘s excipients. With innovative solutions solving challenges like solubility limitations and improving bioavailability, you’ll discover the next generation of pharmaceutical innovations.
Leave a Reply
You must be logged in to post a comment. Need an account? Register here.